Stocktoria
Ultragenyx Pharmaceutical Inc. RARE
Ultragenyx Pharmaceutical Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 5,603,352 | $230.3M | 5.68% |
| AQR CAPITAL MANAGEMENT LLC | 4,578,024 | $95.9M | 4.64% |
| CITADEL ADVISORS LLC | 2,371,391 | $49.7M | 2.41% |
| TWO SIGMA INVESTMENTS, LP | 2,205,820 | $46.2M | 2.24% |
| MILLENNIUM MANAGEMENT LLC | 1,772,184 | $37.1M | 1.8% |
| D. E. Shaw & Co., Inc. | 1,261,018 | $26.4M | 1.28% |
| Point72 Asset Management, L.P. | 893,295 | $18.7M | 0.91% |
| RENAISSANCE TECHNOLOGIES LLC | 561,700 | $11.8M | 0.57% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.